What are the recommended screening tests for liver cysts?

Screening Tests for Liver Cysts

Ultrasound is the definitive first-line and only necessary screening test for liver cysts; once typical simple cyst features are identified, no further imaging with CT or MRI is required. 1, 2

Initial Screening Approach

Ultrasound should be used as the primary screening modality for any suspected liver cyst, whether discovered incidentally or in symptomatic patients. 1, 2 The European Association for the Study of the Liver (EASL) provides this as a strong recommendation with 100% consensus. 1

Why Ultrasound is Optimal for Screening

• Ultrasound demonstrates approximately 90% sensitivity and specificity for diagnosing hepatic cysts. 1, 2
• Simple hepatic cysts appear as anechoic (black) lesions with sharp, smooth borders, thin walls, and strong posterior acoustic enhancement on ultrasound. 2, 3
• Ultrasound is widely available, inexpensive, lacks radiation exposure, and can assess cyst content and wall thickness effectively. 1

When Ultrasound Alone is Sufficient

Once ultrasound confirms a simple cyst with typical features (anechoic, thin-walled, no septations, no debris), no additional imaging with CT or MRI should be ordered. 1, 2 This represents a strong EASL recommendation with 96% consensus. 2

When Additional Imaging is Required

If ultrasound reveals complex characteristics, contrast-enhanced MRI—not CT—should be obtained for further characterization. 2 Complex features requiring additional workup include: 1

• Internal septations
• Mural thickening or nodularity
• Debris-containing fluid
• Wall enhancement
• Calcifications
• Haemorrhagic or proteinaceous contents

Contrast-enhanced ultrasound (CEUS) can be used for complex cysts to identify vascularized septation or wall enhancement, which helps distinguish malignant from benign lesions. 1, 2

Specific Clinical Scenarios

Polycystic Liver Disease (PLD)

PLD is diagnosed when more than 10 hepatic cysts are identified on any imaging modality (ultrasound, CT, or MRI). 1, 2

• MRI is preferred over ultrasound and CT for detecting small cysts, especially in younger patients and those with renal insufficiency. 1, 2
• In the absence of symptoms or complications, no imaging beyond the initial diagnostic study is required. 1

Suspected Hemorrhagic Cyst

Initial evaluation should start with ultrasound to look for heterogeneous hyperechoic mobile material and thin mobile septations suggestive of intracystic clot. 2

• If ultrasound findings are equivocal, contrast-enhanced MRI should be performed; hemorrhagic cysts appear heterogeneous and hyperintense on both T1- and T2-weighted sequences. 2
• CT is not recommended for detecting intracystic hemorrhage because of low reliability. 2 This is a strong EASL recommendation with 91% consensus.

Suspected Infected Cyst

When infection is suspected (fever >38.5°C for >3 days with abdominal tenderness), obtain contrast-enhanced CT or MRI; ultrasound alone is insufficient. 2

• Imaging signs of infection include enhanced wall thickening, perilesional inflammation, or the presence of gas within the cyst. 2

Biliary Hamartomas

Biliary hamartomas should be diagnosed by MRI with heavily T2-weighted sequences and MR cholangiography sequences. 1

• These appear as multiple small (2-10 mm) hyperintense lesions creating a "starry sky" appearance on MRI. 1

Caroli Disease

Magnetic resonance cholangiopancreatography (MRCP) should be performed when imaging shows segmental intrahepatic cystic dilatations. 2

• MRCP provides the highest diagnostic accuracy by visualizing the biliary tree and demonstrating continuity between cystic lesions and draining bile ducts. 2

Laboratory Testing

No bloodwork is required for asymptomatic simple hepatic cysts, as these are benign developmental anomalies. 2 The EASL guidelines explicitly state this.

• Tumor markers (CEA and CA19-9) should not be ordered for hepatic cysts, as they cannot reliably distinguish benign cysts from malignant lesions. 2
• If clinical features suggest infected hepatic cyst, complete blood count and C-reactive protein (CRP) should be ordered to assess for leukocytosis and inflammation. 2
• For polycystic liver disease, renal function testing is mandatory to evaluate for concurrent autosomal dominant polycystic kidney disease (ADPKD). 2

Common Pitfalls to Avoid

Do not order CT or MRI after ultrasound confirms a simple cyst; this adds unnecessary cost without improving outcomes. 2, 4 This is one of the most common errors in clinical practice.

Do not use CT to diagnose cyst hemorrhage; CT is unreliable for this purpose. 2 This represents a strong EASL recommendation with 91% consensus.

Do not order surveillance ultrasounds for asymptomatic simple cysts based on size alone, as this leads to unnecessary healthcare utilization without improving outcomes. 4

Avoid the term "cystadenoma/cystadenocarcinoma" based solely on radiologic examination without pathologic confirmation. 5 Radiologic reporting of "rule out biliary cystadenoma" frequently leads to unnecessary surgery for what are ultimately simple cysts or benign biliary cysts. 6, 5

Follow-Up Recommendations

It is not recommended to follow asymptomatic patients with simple hepatic cysts, biliary hamartomas, or peribiliary cysts. 1, 4 This is a strong EASL recommendation with 96% consensus.

• Ultrasound should be performed only if symptoms develop (abdominal pain, distension, early satiety, nausea, or vomiting). 4
• Routine follow-up imaging after treatment (aspiration sclerotherapy or surgical procedures) is not recommended, as treatment success is defined by symptom relief rather than volume reduction. 1, 4